[ascct] Funding opportunities

  • From: Kristie Sullivan <KSullivan@xxxxxxxx>
  • To: "ascct@xxxxxxxxxxxxx" <ascct@xxxxxxxxxxxxx>
  • Date: Fri, 19 Apr 2013 16:51:48 -0400

Food and Drug Administration CDER
In vitro release tests for topical dermatological products (U01)
Deadline: July 1, 2013

Bioequivalence of topical dermatological products has been a longstanding 
challenge to FDA. An in vitro release test could be used as part of the 
bioequivalence evaluation of topical products. This project will investigate in 
vitro - in vivo correlations of topical dermatological products. The goal is to 
identity in vitro release test conditions that are best correlated with in vivo 
performance. In vivo performance could be assessed by human pharmacokinetic 
(PK) data, human microdialysis data or other proposed source.

Alternative Research and Development Foundation
Deadline: Notification April 23, Application April 30, 2013

The mission of the Alternatives Research and Development Foundation is to fund 
and promote the development, validation and adoption of non-animal methods in 
biomedical research, product testing and education.

Kristie Sullivan
Secretary, ASCCT

This email was sent to members of the American Society for Cellular and 
Computational Toxicology.
Learn more at www.ascctox.org.

To post, send to ascct@xxxxxxxxxxxxx.
To unsubscribe, send an email with the subject line "unsubscribe" to 

To view an archive of list emails, visit www.freelists.org/archive/ascct.

Other related posts: